Brigade Enterprises in May announced its first bonus issue in around seven years, along with the release of its Q4 results. It said its boa...

In an interaction with Kshitij Anand of ETMarkets, Dhawal Dalal, President & CIO – Fixed Income at Edelweiss Mutual Fund, said the combinat...

Amidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...

MTAR Technologies shares fell sharply after its key client, Bloom Energy, saw its stock tumble in the US market following the suspension of...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Helios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...

The Indian rupee is projected to average around 96 against the US dollar in FY27. However, this outlook faces potential challenges includin...

Domestic markets are showing signs of recovery after recent declines, aided by easing geopolitical tensions and softer crude prices. Howeve...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

Indian stock markets closed higher on Tuesday, with Sensex and Nifty posting marginal gains as broader markets surged. The decline in oil p...

Indian stock markets closed higher on Tuesday, with Sensex and Nifty posting marginal gains as broader markets surged. The halt in Iran-Isr...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....

What is Planet Nine, and where is it? The question has fascinated astronomers for years. Scientists believe a massive undiscovered planet m...

BofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...

Nifty 50 earnings growth fell short of expectations in FY25 and FY26. While Q4 FY26 results led to an upward revision for FY27E Nifty 50 EP...

Motilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...

Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...